Search

everythinglearnresearchcommunity

for

Search:↓

Human hair protein modifications could potentially indicate heart disease risk.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Hair follicle sampling is a practical method for measuring biomarkers in children with and without Fragile X syndrome.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

The document concludes that dandruff and seborrheic dermatitis are linked to inflammation and skin changes, and treating them with specific shampoos can reduce these issues.

Low iron levels in the blood could be a sign of Telogen Effluvium, a type of hair loss, but it's not always accurate in distinguishing it from other hair loss types.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Skin health and diseases are closely linked to metabolic processes.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Afro-textured hair needs specialized care due to its unique genetic and structural properties.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Tph cells are linked to the severity of systemic lupus erythematosus.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Developing microRNA-based treatments is hard but has potential.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

New therapies are being developed that target integrin pathways to treat various diseases.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

Certain skin conditions may indicate or increase the risk of Parkinson's disease.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.